Mechanisms of PARP Inhibitors in Targeted Cancer Therapy

Dr Eli Rothenberg is a Professor of Biochemistry & Molecular Pharmacology at New York University Grossman School of Medicine. His lab uses state-of-the-art single-molecule fluorescence imaging to uncover how cells maintain genome integrity and respond to DNA damage. His work explores non-canonical DNA structures and DNA repair pathways in cancer, offering fresh insights into therapy resistance and novel biomarkers. He is a leading, pioneering researcher working at the cutting edge of molecular biophysics and biomedical science.